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Objectives: This study evaluated early and long-term results of endovascular treatment of iliac artery occlusions and
compared these outcomes with those in patients treated for stenotic lesions.
Methods: During a 10-year period ending in January 2010, 223 endovascular procedures to treat aortoiliac occlusive
disease (PAD) were performed. All patients were prospectively enrolled in a dedicated database. The intervention was
performed for iliac occlusion in 109 patients (group 1) and for iliac stenosis in 114 (group 2). Early results were analyzed
and compared by 2 and Fisher exact tests. Follow-up consisted of clinical examination and duplex scanning at discharge,
<3 months, at 6 and 12 months, and yearly thereafter. Follow-up results were analyzed with Kaplan-Meier curves and
compared with the log-rank test.
Results: The two groups had similar risk factors for atherosclerosis and comorbidities. Critical limb ischemia was more
common in group 1 (20.5%) than in group 2 (8.5%; P  .01). Intraoperative technical details were similar, except for a
higher percentage of brachial and contralateral femoral access and more frequent use of nitinol stents in group 1. Two
immediate technical failures occurred, one in both groups, requiring immediate conversion to surgical bypass. Four
intraoperative iliac ruptures occurred, two in each group; all were successfully treated with covered stents. An additional
10 immediate complications occurred (8 in group 1; 2 in group 2), one of which required conversion to open surgical
bypass. The cumulative rate of perioperative complications was 9% in group 1 and 3.5% in group 2 (P  .08). Primary
patency at 30 days was 97.3% and 98.7%, respectively. Mean duration of follow-up was 28.4 months; 203 patients (91%)
had a regular postoperative follow-up visit. At 60 months, primary patency in group 1 vs group 2 was 82.4% vs 77.7%
(P .9), assisted primary patency was 90.6% vs 85.5% (P .4), and estimated secondary patency was 93.1% vs 92.8% (P
.3). The cumulative rate of reintervention during follow-up (excluding reinterventions performed in the perioperative
period) was 2.5% in group 1 and 12.5% in group 2 at 60 months (P  .09). Univariate analysis in group 1 failed to find
any of the examined risk factors significantly affected long-term primary patency rates.
Conclusions: In our experience, endovascular treatment of iliac occlusions provides excellent early and long-term results,
similar to those obtained in the treatment of stenotic lesions. ( J Vasc Surg 2011;53:92-8.)Percutaneous endovascular treatment has become the
initial approach in patients with aortoiliac chronic occlusive
disease. Even if in patients with complex unilateral or
bilateral occlusive disease of the common or external iliac
artery, or both (TransAtlantic InterSociety Consensus
[TASC] II C and D lesions),1 open surgery remains the
recommended approach. Encouraging early and long-term
results have been reported in the endovascular manage-
ment of iliac artery occlusions, particularly when stenting
was performed. However, reported results for technical
success and long-term patency are slightly poorer than
those obtained in the treatment of stenoses.2 The aim of
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92this study was to retrospectively compare immediate and
follow-up results of endovascular management of iliac ar-
tery occlusions and stenoses in a single-center experience.
MATERIAL AND METHODS
From January 2000 to January 2010, 447 consecutive
endovascular procedures for peripheral arterial occlusive
disease in 412 patients were performed at our institution.
Data concerning these interventions were prospectively
collected in a dedicated institutional database containing
main anatomic, clinical, diagnostic, and technical variables.
This database also contains perioperative (30 days) results
and all relevant clinical and diagnostic data collected during
follow-up. A post hoc analysis of this prospective database
found 223 interventions performed for aortoiliac occlusive
disease in 212 patients.
Interventions were retrospectively divided into two
groups: 109 interventions (group 1) performed for unilat-
eral or bilateral occlusion of the common or external iliac
artery, or both (TASC II B, C, and D lesions), and 114
interventions (group 2) performed for unilateral or bilateral
stenosis of the common or external iliac artery (mainly
TASC II A and B lesions).
The two groups of patients were compared by demo-
graphic data, common risk factors for atherosclerosis, and
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smoking habits (current and former, 5 years, smokers)
arterial hypertension (defined as blood pressure 130/80
mm Hg or the need for antihypertensive drugs), hyperli-
pemia (defined as triglycerides and cholesterol values200
mg/dL), coronary artery disease (defined as a history of
myocardial infarction, angina, previous coronary revascu-
larization), diabetes mellitus (defined as the need for spe-
cific drugs), and chronic renal failure (defined as serum
creatinine values 1.5 mg/mL). The Rutherford classifi-
cation3 was used to define clinical status, and TASC II
guidelines1 were used to define the anatomic characteristics
of the lesions.
Preoperative diagnostic assessment consisted of ankle-
brachial index (ABI) measurement and duplex scanning in
all patients. Duplex examinations were performed in our
validated vascular laboratory by First Level Italian Society
for Vascular Investigations certified physicians. Computed
tomography angiography (CTA) of the aorta and iliofem-
oral axis was performed in patients with multilevel disease
and in those with extremely calcified lesions at duplex
scanning.
In patients presenting with recent (14 days) worsen-
ing of symptoms or Rutherford class upgrade and the
evidence of iliac thrombosis, preoperative catheter-directed
thrombolysis with urokinase (Urochinasi Crinos, Crinos
SPA, Milan, Italy) was attempted. Thrombolytic treatment
was administered in a bolus of 100,000 IU, followed by
continuous infusion with a delivery rate of 70,000 IU/h.
All patients were administered 1000 to 1500 IU/h of
sodium heparin through the same catheter to maintain
activated partial thromboplastin time values two times
higher than normal.
Angiographic controls were performed daily or more,
when necessary, and the lytic infusion lasted until patency
of iliac vessels was achieved, or for a maximum of 3 days
when unsuccessful. Thrombolysis was defined as successful
in the presence of restored patency of the targeted vessel,
even in the presence of significant residual stenosis, which
was routinely treated at the end of thrombolytic treatment.
Owing to the presence of underlying stenosis, these pa-
tients were all categorized as group 2.
All the interventions were performed by vascular sur-
geons in the operating room in the first period of the
experience and then in the angiographic suite, under local
anaesthesia, supplemented with intravenous sedation or
analgesia when required.
Stenotic lesions were normally crossed from an ipsilat-
eral approach, with a combination of soft-tip guidewire or
hydrophilic wire and a vertebral 4F catheter. Occlusive
lesions were initially negotiated from an ipsilateral ap-
proach, and if this approach failed, contralateral access was
performed and recanalization of the occlusion was at-
tempted. In patients with short or no proximal iliac stump,
left brachial access was performed.
In patients with complex lesions involving the femoral
bifurcation, a hybrid approach was performed in which a
surgical femoral endarterectomy, with or without patchangioplasty, was followed by endovascular treatment of the
iliac lesion.
After the introducer sheath was placed, administration
of 5000 IU of intravenous sodium heparin was performed
in all cases.
Arterial recanalization in patients in group 1 was achieved
in most cases with a subintimal technique. Balloon-
expandable stents were used preferentially for focal, ostial,
and severely calcified lesions; in case of involvement of
aortic bifurcation, a kissing balloon or kissing stents tech-
nique was done. Self-expanding stents were usually placed
for long-segment diseased or tortuous arteries.
Intraoperative and perioperative data included type of
access, procedure performed (isolated percutaneous trans-
luminal angioplasty [PTA] or stenting), type, number, and
length of stents, associated surgical and endovascular proce-
dures, concomitant treatment of outflow vessels, and postop-
erative medical treatment with single- or dual-antiplatelet
therapy or oral anticoagulants. The choice for dual- or
single-antiplatelet therapy was not standardized but was at
the surgeon’s discretion and also according to the patient’s
socioeconomic status. Oral anticoagulants were prescribed
only to patients who already had undergone this treatment
for comorbidities.
Early (intraoperative and 30 days) results were ana-
lyzed for technical success (defined as a 20% residual
stenosis at completion angiography), conversion to open
surgery (defined as technical failure, followed by immediate
surgical repair), primary patency (defined as uninterrupted
patency without procedures performed on or at the margin
of the treated segment), secondary patency (defined as
restored patency through the original treated segment),
and for patients with critical limb ischemia, limb salvage
(defined as the avoidance of above or below knee amputa-
tion).
The postoperative follow-up program consisted of clin-
ical examination and duplex scanning with ABI measure-
ment 3 months, at 6 and 12 months, and yearly thereaf-
ter. All ultrasound studies were performed using an Acuson
Sequoia 512 Ultrasound System (Acuson Corp, Mountain
View, Calif).
Loss of primary patency was diagnosed when ABI
deterioration20% was associated with duplex evidence of
significant (50%) restenosis, requiring or not a secondary
intervention to maintain arterial patency or thrombosis of
the treated segment. In the presence of flow-limiting le-
sions associated with recurrence or impairment of symp-
toms, patients underwent digital subtraction angiography
for the endovascular treatment.
Follow-up results were analyzed for survival, primary
and secondary patency, assisted primary patency (defined as
the success of procedures done on a still patent segment to
prevent its thrombosis), and for patients with critical isch-
emia, limb salvage.
Statistical analysis was performed by means of SPSS
15.0 software (SPSS Inc, Chicago, Ill). Early results were
analyzed with 2 test and Fisher exact test, when necessary.
Univariate and multivariate analysis (stepwise logistic re-
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group 1were performed. Statistical significance was defined
as a value of P  .05.
Follow-up data were analyzed by Kaplan-Meier life-
table analysis, and results in the two groups were compared
by means of the log-rank test. Univariate and multivariate
analysis (Cox’s regression) of the factors affecting late re-
sults in patients of group 1 were performed.
RESULTS
Demographic data and clinical and anatomic status.
There were no differences between the two groups in sex,
age, risk factors for atherosclerosis, and comorbidities (Ta-
ble I). Intervention was performed for critical limb ischemia
in 23 patients (20.5%) in group 1 and in 10 patients (8.5%)
in group 2 (P  .01). The remaining patients had severe
intermittent claudication. The Rutherford classification in
both groups is reported in Table II. The preoperative mean
ABI was 0.50 0.26 and was significantly lower in group 1
(0.44  0.25) than in group 2 (0.57  0.27; P  .001).
In 58 group 1 patients, the targeted vessels had TASC
II C and D lesions; in group 2, only 1 patient had a type D
lesion, and type A or B disease was present in the remaining
patients. TASC II classification in both groups is reported
in Table II.
Operative details. In the entire study group, percuta-
Table I. Demographic data, risk factors, and
comorbidities
Variable Group 1 Group 2 P
Interventions, No. 109 114
Female sex, No. (%) 22 (20) 31 (27) .2
Median age, years (range) 66.3 (37-87) 65.7 (34-84) .2
History of smoking, No. (%) 87 (80) 89 (78) .09
Hyperlipemia, No. (%) 66 (60) 60 (53) .06
Arterial hypertension, No. (%) 80 (73) 87 (76) .08
Diabetes mellitus, No. (%) 20 (18) 25 (22) .06
Coronary artery disease, No. (%) 32 (29) 33 (29) .08
Chronic renal failure, No. (%) 6 (5) 2 (2) .09
Table II. Clinical and anatomic status
Classification
Group 1 Group 2
P
(n  109) (n  114)
No. (%) No. (%)
Rutherford
Class 3 86 (79.5) 104 (91.5) .05
Class 4 14 (13) 3 (2.5) .003
Class 5 9 (7.5) 6 (5) .5
Class 6 . . . 1 (1) .1
TASC II
Type A . . . 112 (98) .001
Type B 52 (48.5) 1 (1) .001
Type C 25 (22) . . . .001
Type D 32 (29.5) 1 (1) .001
TASC, TransAtlantic InterSociety Consensus.neous ipsilateral femoral access was used in 109 interven-tions, percutaneous contralateral femoral access was used in
50 interventions, and percutaneous brachial access was
used in 38 interventions. An ipsilateral open surgical fem-
oral approach was used in 28 interventions. Patients in
group 1 hadmore frequent contralateral and brachial access
than patients in group 2; whereas in patients in group 2,
targeted lesions were more frequently approached using an
ipsilateral percutaneous puncture (Table III).
The lesions were successfully crossed in all but one pa-
tient. Isolated percutaneous transluminal angioplasty was per-
formed in 12 in group 1 (11%) and in 13 in group 2 (11.5%;
P  .9). One or more stents were placed in the remaining
cases. Themean number of placed stents was 1.91 in group
1 and 1.1  0.5 in group 2 (P  .001). The mean length of
treated arterial segments was 126.7 71 mm in group 1 and
52.1 35.1 mm in group 2 (P .001).
Twenty different types of commercially available stents
were used. A nitinol stent was used in 106 patients, a steel
stent was used in 84, and a covered stent was placed in the
rest. The distribution of the stent type in the two groups is
listed in Table III. In group 1, nitinol stents were more
commonly used, whereas in group 2, steel stents were more
frequently implanted. The kissing stent technique was used
in 24 cases in group 1 (22%) and in 10 cases in group 2
(8.5%; P  .05).
Intra-arterial thrombolysis with urokinase was per-
formed in nine patients with recent symptoms, impairment,
and angiographic evidence of iliac occlusion. Mean dura-
tion of thrombolytic treatment was 48 hours (range, 24-72
hours). Thrombolysis was successful in all but one patient,
unmasking the presence of a stenotic lesions, which were
treated with PTA, with or without stenting, 24 hours
from the cessation of urokinase administration. As a conse-
quence, these nine patients were categorized in group 2.
Concomitant open surgical intervention was per-
formed in 26 patients (15 in group 1 and 11 in group 2;
P  .4). Associated open interventions were performed in
all but five patients who had surgical femoral access, in two
patients who had brachial access, and in one patient who
had percutaneous contralateral femoral access. The associ-
Table III. Technical details
Variable
Group 1 Group 2
P
(n  109) (n  114)
No. (%) No. (%)
Vascular access
Percutaneous
Ipsilateral femoral 29 (26.5) 80 (70) .001
Contralateral femoral 31 (28.5) 17 (15) .05
Brachial 33 (30) 5 (4.5) .001
Surgical ipsilateral femoral 16 (14.5) 12 (10.5) .3
(n  97) (n  101)
Type of stent
Nitinol 68 (70) 38 (37.5) .001
Steel 24 (25) 60 (59.5) .001
Covered stent 5 (5) 3 (3) .1
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ated endovascular procedure of the femoropopliteal axis
was performed in 18 patients (8 in group 1 and 10 in group
2, P  .7). The associated endovascular interventions are
listed in Table IV.
Postoperative medical treatment consisted of lifelong
dual-antiplatelet therapy in 174 patients and single-
antiplatelet therapy in 40. In nine patients who took oral
anticoagulants before the procedure, the therapeutic regi-
men was continued after discharge. There were no differ-
ences between the two groups in postoperative medical
treatment (Table IV).
Perioperative and early (<30 days) results. Technical
success was 98.9%. Two procedures failed: In one patient of
group 1, treated for left common iliac occlusion and steno-
sis of the contralateral common iliac artery, the iliac occlu-
sion could not be crossed and immediate conversion to
aortobifemoral bypass was necessary. The other patient,
treated for common iliac stenosis, required conversion to
aortobifemoral bypass because of an immediate stent mi-
gration in the abdominal aorta.
Four intraoperative iliac ruptures occurred, two in each
group, and all were successfully treated with a covered
stent. An additional 10 immediate complications occurred,
8 in group 1 and 2 in group 2 (Table V), of which one
conversion to open surgical bypass was required. The cu-
mulative rate of perioperative complications was 9% in
group 1 and 3.5% in group 2 (P .08), whereas the rate of
conversion to open surgery was 1.8% and 0.9%, respec-
tively, without differences between the groups.
The mean postoperative ABI was 0.88  0.17, with a
significant improvement compared with preoperative val-
ues (P  .001) in group 1 (0.87  0.19; P  .001) and in
group 2 (0.89  0.15; P  .001).
At 30 days, no deaths or major cardiovascular compli-
Table IV. Associated open and endovascular procedures
and postoperative medical treatment in both groups
Variable
Group 1 Group 2
P
(n  109) (n  114)
No. (%) No. (%)
Associated open procedures
Femoral endarterectomy 14 (13) 4 (3.5) .05
Femoral-femoral bypass 1 (1) 3 (2.5) .5
Femoral-popliteal bypass . . . 4 (3.5) .07
Associated endovascular procedures
Ipsilateral SFA PTA 6 (5.5) 4 (3.5) .3
Ipsilateral SFA stenting 1 (1) 3 (2.5) .07
Ipsilateral tibial PTA . . . 1 (1) .3
Contralateral SFA PTA . . . 2 (1.8) .2
Renal stenting 1 (1) . . . .3
Postoperative treatment
Single antiplatelet 23 (21) 17 (15) .4
Dual antiplatelet 81 (74) 93 (81) .4
Oral anticoagulant 5 (5) 4 (4) .1
PTA, Percutaneous transluminal angioplasty; SFA, superficial femoral ar-
tery.cations occurred. No new thrombosis or significant reste-nosis was noted at the early postoperative follow-up visit.
Primary patency at 30 days was 97.3% and secondary pa-
tency was 98.7%, without differences between the two
groups.
At univariate analysis for the risk of perioperative com-
plications in group 1, only postoperative treatment with
oral anticoagulants was significantly associated with an
increased risk (odds ratio, 4.8; 95% confidence interval;
0.9-15.7; P  .04), but this was not seen on multivariate
analysis.
Follow-up results. Median duration of follow-up was
18 months (interquartile range, 9-36 months) and was
significantly longer in group 2 (30months) than in group 1
(12 months, P  .001). A total of 203 patients (91%) had
regular postoperative follow-up visits.
During follow-up, 12 deaths occurred, 5 in group 1
and 7 in group 2. The cause of death was cardiac in 4
patients, cancer in 5, acute accidental overdose of psycho-
tropic drugs in 1 patient, and was unknown in the remain-
ing 2 patients. Estimated 60-month survival rates were
82.5% (standard error [SE], 0.1) in group 1 and 86.3% (SE,
0.05) in group 2 (P  .7; log-rank, 0.09).
Significant restenosis of the treated vessel occurred in
14 patients in the whole study group, 4 in group 1 and 10
in group 2. In all but 2 patients the restenosis was success-
fully treated—in 11 with a new endovascular procedure (5
stent placements, 2 new PTA, 3 cutting-balloon proce-
dures, and 1 combined PTA and femoral endarterectomy)
and in 1 with an iliofemoral endarterectomy. Restenosis in
the remaining patients was asymptomatic, and they were
medically managed, without developing occlusion or clin-
ical impairment during follow-up.
Seven new thromboses were recorded during follow-
up, four in group 1 and three in group 2. In group 1, a new
Table V. Intraoperative results
Variable
Group 1 Group 2
P
(n  109) (n  114)
No. (%) No. (%)
Technical failure 1 (0.9) 1 (0.8) .99
Intraoperative complications
Rupture 2 (1.8) 2 (1.5) .99
Immediate complications
Arterial dissection . . . 1a
Iliac thrombosis 1b 1c
Femoral thrombosis 2d . . .
Brachial thrombosis 3e . . .
Femoral pseudoaneurysm 1f . . .
Distal embolization 1g . . .
Cumulative intra-op complications 10 (9) 4 (3.5) .08
NS, Not significant.
aTreated with stent placement.
bTreated with conversion to aortobifemoral bypass.
cTreated with surgical thrombectomy and femoral patching.
dOne patient was treated with thromboaspiration and one with surgical
thrombectomy and femoral patching.
eAll treated with brachial thrombectomy.
fTreated with open repair.
gTreated with thrombolysis and distal percutaneous transluminal angio-
plasty.
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been treated in the perioperative period with a femoral
thrombectomy and patching for acute thrombosis, and
conversion was required to open aortobifemoral bypass.
Another patient presented a thrombosis in postoperative
month 7 and was treated with thrombolysis and kissing
stent of the aortic bifurcation. The same patient showed a
new acute thrombosis at 30 months and underwent con-
version to aortobifemoral bypass. An additional patient
sustained thrombosis at 8 months and was successfully
treated with intra-arterial thrombolysis and restenting. The
remaining patient, showing an occlusion at 24months with
mild claudication, was managed medically.
In group 2, one acute thrombosis occurred at 24 months
and required conversion to aortobifemoral bypass; another
patient had recurrent stenting for thrombosis at 30 months,
whereas in the remaining occlusion, occurring at 50 months,
medicalmanagement due to the presence ofmild claudication
was chosen. No amputation was recorded.
Primary patency rates at 60 months were 82.4% (SE,
0.06) in group 1 and 77.7% (SE, 0.06) in group 2 (P .9,
log-rank 0.05; Fig 1). The corresponding rates of assisted
primary patency were 90.6% (SE, 0.04) and 85.5% (SE,
0.06), respectively (P  .4; log-rank, 0.6).
Estimated secondary patency rates at 60 months were
93.1% (SE, 0.03) in group 1 and 92.8% (SE, 0.05) in group
2 (P  .3; log-rank, 1; Fig 2). At the same time interval,
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Fig 1. Kaplan-Meier curve for primary patency during follow-up
is shown for groups 1 and 2, with numbers of patients at risk.freedom from conversion to open surgery was 89.5% (SE,0.07) in group 1 and 97.2% (SE, 0.03) in group 2 (P .4;
log-rank, 0.6). At 60 months of follow-up, the cumulative
rate of reintervention (excluding reinterventions per-
formed in the intraoperative and immediate perioperative
period) was 2.5% (SE, 0.02) in group 1 and 12.5% (SE,
0.05) in group 2 (P  .09, log-rank 2.7; Fig 3).
Univariate analysis in group 1 failed to find that any of
the examined risk factors significantly affected primary pa-
tency rates (Table VI).
DISCUSSION
Endovascular surgery has become the initial therapeu-
tic option for aortoiliac occlusive disease due to the sub-
stantial risk of perioperative complications during open
surgery4 and the significant improvement in endovascular
techniques and materials. Endovascular treatment has been
proven to be safe and effective, particularly in focal iliac
artery stenosis, with high rates of technical success and
excellent long-term patency rates.1,5 Although TASC
guidelines still recommend surgical treatment in the case of
complex, multifocal or totally occluded segments of iliac
arteries (TASC II types C and D iliac lesions), the recent
advancements in endovascular techniques have led to an
extension of the indications to more extensive aortoiliac
occlusive disease, with satisfactory early and long-term re-
sults.6,7 A recent literature review2 reported overall slightly
better results in the treatment of iliac stenosis than iliac occlu-
sions in immediate success and long-term patency. However,
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Fig 2. Kaplan-Meier curve for secondary patency during follow-up
is shown for groups 1 and 2, with numbers of patients at risk.
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54% to 92% at 5 years for stenoses and 48% to 85% at 3 years
for occlusions, and only a limited number of studies directly
compared results in occlusions and stenoses.8
The paucity of data concerning this comparison may be
because most studies categorize and analyze patients by the
TASC classification,9,10 which often includes in the same class
awide range of different lesions, both occlusions and stenoses.
In this study, we have retrospectively analyzed our early
and long-term results of endovascular treatment of occlu-
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Fig 3. Kaplan-Meier curve for freedom from new reinterventions
(excluding reinterventions performed in the intraoperative and
immediate perioperative period) during follow-up is shown for
groups 1 and 2, with numbers of patients at risk.
Table VI. Univariate analysis for factors affecting follow-
up primary patency in group 1
Factor Log-rank OR 95% CI P
Female sex 2.8 2.8 0.8-10 .09
Diabetes 0.5 0.6 0.1-2.3 .4
Critical limb ischemia 1.7 2.4 0.6-9.7 .2
TASC C/D lesions 0.5 1.6 0.4-5.7 .4
Isolated PTA 0.02 1 0.1-8.3 .9
Arterial access 1.5 1.2 0.6-2.2 .7
Hybrid procedure 0.01 1.1 0.1-8.9 .9
Stent type 1.9 1.9 0.7-4.9 .4
Post-op drug therapy 2.8 1.1 0.1-10.7 .2
CI, Confidence interval; OR, odds ratio; PTA, percutaneous transluminal
angioplasty; TASC, TransAtlantic InterSociety Consensus.sive aortoiliac disease, comparing patients treated for iso-lated or multiple stenoses and patients treated for occlu-
sions. Even if patients in group 1 were more likely than
patients in group 2 to have critical limb ischemia, most
patients in both groups had severe intermittent claudica-
tion, a common finding in most published series, where the
percentage of claudicants is between 50% and 100%.2
Percutaneous femoral access was performed inmost cases;
however, as expected, patients in group 1 more frequently
underwent contralateral femoral and brachial access. Surpris-
ingly, we found no difference between the two groups in the
percentage of ipsilateral femoral surgical access, probably due
to the procedures performed for stenotic lesions early in our
experience, when we had a more cautious approach to the
common femoral artery. Moreover, we preferred surgical ac-
cess whenever significant femoral lesions were present. Cur-
rently in our practice, the femoral surgical approach is reserved
for complex occlusive lesions, similarly to what is reported in
most published studies.11,12
Our policy in iliac occlusion is to attempt to endolumi-
nally cross the lesion; this was impossible in many cases, and
a subintimal route was used. We prefer in these cases an
anterograde access to reduce, in case of no re-entry, the
possible retrograde dissection of the aorta; in addition, we
have more pushability of the system and easier control of
the guidewire. By adopting this strategy, we have achieved
a high rate of technical success.
One or more stents were placed in most patients in
both groups. As expected in group 1, a significantly higher
number of stents were placed covering a longer arterial
segment, confirming what is generally accepted in clinical
practice,13 that it is better to perform a direct or primary
stenting in patients with chronic occlusion. The high num-
ber of placed stents also in group 2 can be possibly related
to the influence of the randomized trials published in the
late 1990s14,15 on our early and intermediate experience.
The choice of the type of stent in our series reflects the
current opinions and guidelines2: we preferred steel stents in
patients with short, calcified ostial stenoses, whereas self-
expandable nitinol stents were commonly used in patients
with longer occlusions. Covered stents were used only to bail
out the procedure (ruptures) and in rare cases of very complex
lesions when complications could be expected.
Perioperative and early results were satisfactory, with an
excellent rate of technical success and significant hemody-
namic improvement in both groups. Several intraoperative
and immediate complications were recorded, however, with a
threefold increased risk of complications in group 1 that only
approached significance, probably due to the low number of
cases (type II statistical error). Similarly, Ozkan et al16 re-
ported in their large series concerning early and late results of
endovascular treatment of chronic iliac occlusion a complica-
tion rate of 19%, successfully treated in most cases with an
endovascular procedure. A pooled analysis of 38 studies of
iliac PTA and of 18 studies of stenting2 reported a complica-
tion rate of 2.7% and 6%, respectively; however, the results
were not separately analyzedbetween stenoses andocclusions.
Interestingly, we did not find any association between clinical,
anatomic, and technical factors, and the occurrence of periop-
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the run-off, the length of occlusive lesions, and the type of
approach to the treated vessels have all been found, in different
studies,2,6,16 to significantly affect the rate of complications.
These factors were not significant in our series; however, the
low number of events could have influenced this finding. A
combination of open and endovascular procedures was used
to treat our immediate complications. Once the complication
was treated, the risk of further adverse events was minimal,
with a 30-day patency rate97% in both groups.
Follow-up results demonstrated satisfactory primary,
assisted primary, and secondary patency rates, with no
difference between the groups. The main limit in the anal-
ysis and interpretation of follow-up data is represented by
the significantly different duration of surveillance between
the two groups. We did find a higher percentage of signif-
icant restenosis in group 2 patients, even if not statistically
significant. The explanation for this finding is uncertain;
apart from the mentioned difference in follow-up duration,
we believe it could be also related to the more “focal”
treatment of lesions in the stenosis group (ie, a lower
number of placed stents and shorter covered arterial seg-
ments). A wider use of covered stents in the future probably
could answer some questions regarding the rate of in-stent
restenosis that still remains substantial with the bare stent.
In most cases, however, restenosis was successfully treated
with an endovascular approach, confirming the effective-
ness of such a strategy.17
The percentage of conversion to open repair was higher in
group 1 patients than in group 2 patients, probably influenced
by a perioperatively higher rate of surgical conversion in pa-
tients treated for iliac occlusion. During follow-up, however,
the rate of conversion in the two groups was similarly low.
Furthermore, when excluding the need for reinterventions
in the perioperative and immediate postoperative period,
we found a trend toward higher percentages of reinterven-
tions in group 2, suggesting the need for prolonged sur-
veillance during follow-up in patients treated for stenotic
lesions and also confirming the good durability of endovas-
cular treatment of chronic iliac occlusions.
CONCLUSIONS
In our experience, endovascular treatment of iliac oc-
clusions provides excellent early and long-term results,
similar to those obtained in the treatment of stenotic lesion.
The rate of perioperative complications is higher in the
treatment of occlusive lesions; however, most of these can
be managed endovascularly. The use of hybrid procedures
of the femoral artery may improve outcomes with complex
iliac lesions. These data support our current practice of an
initial endovascular approach to manage iliac occlusions.
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